Product
Lu AF82422
2 clinical trials
2 indications
Indication
Multiple System AtrophyIndication
Healthy ParticipantsClinical trial
Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of Lu AF82422 in Patients With Multiple System AtrophyStatus: Active (not recruiting), Estimated PCD: 2023-11-16
Clinical trial
Interventional, Randomized, Open-label, Parallel-group, Single-dose Trial Investigating the Safety, Immunogenicity, Tolerability, and Pharmacokinetic Properties of Lu AF82422 in Healthy Chinese and Caucasian ParticipantsStatus: Active (not recruiting), Estimated PCD: 2024-09-05